Literature DB >> 16378773

Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Mary McNaughton-Collins1, Michael J Barry.   

Abstract

Many men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia can be managed safely and effectively by primary care providers. After a basic evaluation to exclude other diseases that may cause lower urinary tract symptoms, quantifying the degree of symptoms and bother, and perhaps making an assessment of prostate size, the primary care provider can determine which men require immediate evaluation by a urologist and which men may choose among various treatment options, including watchful waiting and various single agent or combination medication strategies. Recent information about risk factors for disease progression has also helped to inform patient decisions on which treatment option is best for the individual patient. The purpose of this review is to provide primary care providers with an approach to the management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378773     DOI: 10.1016/j.amjmed.2004.12.033

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia.

Authors:  Bilal Chughtai; Dean S Elterman; Richard Lee; Alexis E Te; Steven A Kaplan
Journal:  Ther Adv Urol       Date:  2012-10

2.  National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men.

Authors:  James Doolin; Zachary A Reese; Kenneth J Mukamal
Journal:  World J Urol       Date:  2020-05-24       Impact factor: 4.226

3.  Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-08-01

Review 4.  Pharmacological effects of saw palmetto extract in the lower urinary tract.

Authors:  Mayumi Suzuki; Yoshihiko Ito; Tomomi Fujino; Masayuki Abe; Keizo Umegaki; Satomi Onoue; Hiroshi Noguchi; Shizuo Yamada
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

5.  Integrated Item Response Theory Modeling of Multiple Patient-Reported Outcomes Assessing Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.

Authors:  Yassine Kamal Lyauk; Trine Meldgaard Lund; Andrew C Hooker; Mats O Karlsson; Daniël M Jonker
Journal:  AAPS J       Date:  2020-07-29       Impact factor: 4.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.